Responses
Royal Society of Medicine, Colt Foundation Research Prize Finalists
4 Early identification of high-risk individuals for combination monoclonal antibody therapy is feasible by SARS-CoV-2 anti-spike antibody specific lateral flow assay
Compose a Response to This Article
Other responses
No responses have been published for this article.